Skip to main content
SpringerLink
Log in

Gastrointestinal Tract and Endocrine System

  • Chapter
  • First Online:
Regenerative Medicine - from Protocol to Patient

  • 604 Accesses

Abstract

The absorption of nutrients in the small intestine and the control of blood glucose levels are crucial to ensure energy homeostasis of the organism. These functions can be severely impaired by diseases like type I diabetes, short bowel syndrome, and inflammatory bowel disease, for which the standard treatment involves either life-long replacement, immunosuppression, or transplantation, and is often not satisfactory. After outlining the diseases and established as well as experimental approaches, this chapter summarizes recent preclinical and clinical studies on novel therapeutic options relating to regenerative medicine, including growth factors and stem cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Abramowicz D, Schandene L, Goldman M, Crusiaux A, Vereerstraeten P, De Pauw L, Wybran J, Kinnaert P, Dupont E, Toussaint C (1989) Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 47:606–608

    Article  CAS  PubMed  Google Scholar 

  • Agardh CD, Cilio CM, Lethagen A, Lynch K, Leslie RD, Palmer M, Harris RA, Robertson JA, Lernmark A (2005) Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes. J Diabetes Complications 19:238–246

    Article  PubMed  Google Scholar 

  • Agardh CD, Lynch KF, Palmer M, Link K, Lernmark A (2009) GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes. Diabetologia 52:1363–1368

    Article  CAS  PubMed  Google Scholar 

  • Alexander T, Bondanza A, Muraro PA, Greco R, Saccardi R, Daikeler T, Kazmi M et al (2015) SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking. Bone Marrow Transplant 50:173–180

    Article  CAS  PubMed  Google Scholar 

  • Anderson MS, Bluestone JA (2005) The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23:447–485

    Article  CAS  PubMed  Google Scholar 

  • Ardizzone S, Bianchi PG (2002) Inflammatory bowel disease: new insights into pathogenesis and treatment. J Intern Med 252:475–496

    Article  CAS  PubMed  Google Scholar 

  • Atkinson MA, Leiter EH (1999) The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 5:601–604

    Article  CAS  PubMed  Google Scholar 

  • Atkinson MA, Maclaren NK (1994) The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331:1428–1436

    Article  CAS  PubMed  Google Scholar 

  • Atkinson MA, Maclaren NK, Luchetta R (1990) Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39:933–937

    Article  CAS  PubMed  Google Scholar 

  • Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449:1003–1007

    Article  CAS  PubMed  Google Scholar 

  • Battaglia M, Stabilini A, Roncarolo MG (2005) Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105:4743–4748

    Article  CAS  PubMed  Google Scholar 

  • Belchior GG, Sogayar MC, Grikscheit TC (2014) Stem cells and biopharmaceuticals: vital roles in the growth of tissue-engineered small intestine. Semin Pediatr Surg 23:141–149

    Article  PubMed  Google Scholar 

  • Belghith M, Bluestone JA, Barriot S, Megret J, Bach JF, Chatenoud L (2003) TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 9:1202–1208

    Article  CAS  PubMed  Google Scholar 

  • Birk OS, Elias D, Weiss AS, Rosen A, van-der Zee R, Walker MD, Cohen IR (1996) NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells. J Autoimmun 9:159–166

    Article  CAS  PubMed  Google Scholar 

  • Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293–300

    Google Scholar 

  • Bockova J, Elias D, Cohen IR (1997) Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies. J Autoimmun 10:323–329

    Article  CAS  PubMed  Google Scholar 

  • Bonner-Weir S (1994) Regulation of pancreatic beta-cell mass in vivo. Recent Prog Horm Res 49:91–104

    CAS  PubMed  Google Scholar 

  • Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE (1993) A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 42:1715–1720

    Article  CAS  PubMed  Google Scholar 

  • Bonner-Weir S, Li WC, Ouziel-Yahalom L, Guo L, Weir GC, Sharma A (2010) Beta-cell growth and regeneration: replication is only part of the story. Diabetes 59:2340–2348

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bougneres PF, Landais P, Boisson C, Carel JC, Frament N, Boitard C, Chaussain JL, Bach JF (1990) Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin. Diabetes 39:1264–1272

    Article  CAS  PubMed  Google Scholar 

  • Bouwens L, Pipeleers DG (1998) Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia 41:629–633

    Article  CAS  PubMed  Google Scholar 

  • Bresson D, von Herrath M (2007) Moving towards efficient therapies in type 1 diabetes: to combine or not to combine? Autoimmun Rev 6:315–322

    Article  CAS  PubMed  Google Scholar 

  • Bresson D, Togher L, Rodrigo E, Chen Y, Bluestone JA, Herold KC, von Herrath M (2006) Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J Clin Invest 116:1371–1381

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brignier AC, Gewirtz AM (2010) Embryonic and adult stem cell therapy. J Allergy Clin Immunol 125:336–344

    Article  Google Scholar 

  • Buchman AL, Katz S, Fang JC, Bernstein CN, Abou-Assi SG (2010) Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn’s disease. Inflamm Bowel Dis 16:962–973

    Article  PubMed  Google Scholar 

  • Burchfield JS, Dimmeler S (2008) Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogenesis Tissue Repair 1:4

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Burdon TJ, Paul A, Noiseux N, Prakash S, Shum-Tim D (2011) Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential. Bone Marrow Res 2011:207326. doi:10.1155/2011/207326. Epub 2010 Dec 6

    Article  PubMed  Google Scholar 

  • Burt RK, Craig RM, Milanetti F, Quigley K, Gozdziak P, Bucha J, Testori A, Halverson A, Verda L, de Villiers WJ, Jovanovic B, Oyama Y (2010) Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up. Blood 116:6123–6132

    Article  CAS  PubMed  Google Scholar 

  • Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD (2004) Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Diabetes Care 27:2628–2635

    Article  CAS  PubMed  Google Scholar 

  • Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003a) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110

    Article  CAS  PubMed  Google Scholar 

  • Butler AE, Janson J, Soeller WC, Butler PC (2003b) Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52:2304–2314

    Article  CAS  PubMed  Google Scholar 

  • Byrne TA, Morrissey TB, Nattakom TV, Ziegler TR, Wilmore DW (1995a) Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN J Parenter Enteral Nutr 19:296–302

    Article  CAS  PubMed  Google Scholar 

  • Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW (1995b) A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg 222:243–254

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cardona K, Milas Z, Strobert E, Cano J, Jiang W, Safley SA, Gangappa S, Hering BJ, Weber CJ, Pearson TC, Larsen CP (2007) Engraftment of adult porcine islet xenografts in diabetic nonhuman primates through targeting of costimulation pathways. Am J Transplant 7:2260–2268

    Article  CAS  PubMed  Google Scholar 

  • Carteron NL, Schimenti CL, Wofsy D (1989) Treatment of murine lupus with F(ab’)2 fragments of monoclonal antibody to L3T4. Suppression of autoimmunity does not depend on T helper cell depletion. J Immunol 142:1470–1475

    CAS  PubMed  Google Scholar 

  • Cassinotti A, Annaloro C, Ardizzone S, Onida F, Della VA, Clerici M, Usardi P, Greco S, Maconi G, Porro GB, Deliliers GL (2008) Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn’s disease. Gut 57:211–217

    Article  CAS  PubMed  Google Scholar 

  • Chatenoud L, Baudrihaye MF, Kreis H, Goldstein G, Schindler J, Bach JF (1982) Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody. Eur J Immunol 12:979–982

    Article  CAS  PubMed  Google Scholar 

  • Chatenoud L, Thervet E, Primo J, Bach JF (1994) Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci U S A 91:123–127

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chatenoud L, Primo J, Bach JF (1997) CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J Immunol 158:2947–2954

    CAS  PubMed  Google Scholar 

  • Chen C, Lee WH, Yun P, Snow P, Liu CP (2003) Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes. J Immunol 171:733–744

    Article  CAS  PubMed  Google Scholar 

  • Cho YB, Lee WY, Park KJ, Kim M, Yoo HW, Yu CS (2013) Autologous adipose tissue-derived stem cells for the treatment of Crohn’s fistula: a phase I clinical study. Cell Transplant 22:279–285

    Article  PubMed  Google Scholar 

  • Chung CH, Hao E, Piran R, Keinan E, Levine F (2010) Pancreatic beta-cell neogenesis by direct conversion from mature alpha-cells. Stem Cells 28:1630–1638

    Article  CAS  PubMed  Google Scholar 

  • Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA, Ubezio C, Minelli A et al (2011) Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn’s disease. Gut 60:788–798

    Article  PubMed  Google Scholar 

  • Cosimi AB, Burton RC, Colvin RB, Goldstein G, Delmonico FL, LaQuaglia MP, Tolkoff-Rubin N, Rubin RH, Herrin JT, Russell PS (1981) Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation 32:535–539

    Article  CAS  PubMed  Google Scholar 

  • Couri CE, Voltarelli JC (2009) Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials. Diabetol Metab Syndr 1:19

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM, Madeira MI, Malmegrim KC, Foss-Freitas MC, Simoes BP, Martinez EZ, Foss MC, Burt RK, Voltarelli JC (2009) C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 301:1573–1579

    Article  CAS  PubMed  Google Scholar 

  • Couzin-Frankel J (2010) Immunology. Replacing an immune system gone haywire. Science 327:772–774

    Article  CAS  PubMed  Google Scholar 

  • Craig RM, Traynor A, Oyama Y, Burt RK (2003) Hematopoietic stem cell transplantation for severe Crohn’s disease. Bone Marrow Transplant 32(Suppl 1):S57–S59

    Article  CAS  PubMed  Google Scholar 

  • Cucca F, Muntoni F, Lampis R, Frau F, Argiolas L, Silvetti M, Angius E, Cao A, De Virgiliis S, Congia M (1993) Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum Immunol 37:85–94

    Article  CAS  PubMed  Google Scholar 

  • Dahly EM, Miller ME, Lund PK, Ney DM (2004) Postreceptor resistance to exogenous growth hormone exists in the jejunal mucosa of parenterally fed rats. J Nutr 134:530–537

    CAS  PubMed  Google Scholar 

  • Daneman D (2006) Type 1 diabetes. Lancet 367:847–858

    Article  CAS  PubMed  Google Scholar 

  • Daniel D, Wegmann DR (1996) Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci U S A 93:956–960

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • de la Portilla F, Alba F, Garcia-Olmo D, Herrerias JM, Gonzalez FX, Galindo A (2013) Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I/IIa clinical trial. Int J Colorectal Dis 28:313–323

    Article  PubMed  Google Scholar 

  • Denson LA, Kim MO, Bezold R, Carey R, Osuntokun B, Nylund C, Willson T, Bonkowski E, Li D, Ballard E, Collins M, Moyer MS, Klein DJ (2010) A randomized controlled trial of growth hormone in active pediatric Crohn disease. J Pediatr Gastroenterol Nutr 51:130–139

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dieckgraefe BK, Korzenik JR (2002) Treatment of active Crohn’s disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet 360:1478–1480

    Article  PubMed  Google Scholar 

  • Ditschkowski M, Einsele H, Schwerdtfeger R, Bunjes D, Trenschel R, Beelen DW, Elmaagacli AH (2003) Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation. Transplantation 75:1745–1747

    Article  PubMed  Google Scholar 

  • Dor Y, Brown J, Martinez OI, Melton DA (2004) Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41–46

    Article  CAS  PubMed  Google Scholar 

  • Drakos PE, Nagler A, Or R (1993) Case of Crohn’s disease in bone marrow transplantation. Am J Hematol 43:157–158

    Article  CAS  PubMed  Google Scholar 

  • Drucker DJ (2003) Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol 17:161–171

    Article  CAS  PubMed  Google Scholar 

  • Drucker DJ, Erlich P, Asa SL, Brubaker PL (1996) Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A 93:7911–7916

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Duijvestein M, Vos AC, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, Kooy-Winkelaar EM, Koning F, Zwaginga JJ, Fidder HH, Verhaar AP, Fibbe WE, van den Brink GR, Hommes DW (2010) Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: results of a phase I study. Gut 59:1662–1669

    Article  PubMed  Google Scholar 

  • Dungan KM, Buse JB, Ratner RE (2009) Effects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP). Diabetes Metab Res Rev 25(6):558–565. doi:10.1002/dmrr.999

    Article  CAS  PubMed  Google Scholar 

  • Edinger M, Hoffmann P (2011) Regulatory T cells in stem cell transplantation: strategies and first clinical experiences. Curr Opin Immunol 23:679–684

    Article  CAS  PubMed  Google Scholar 

  • Elias D, Cohen IR (1994) Peptide therapy for diabetes in NOD mice. Lancet 343:704–706

    Article  CAS  PubMed  Google Scholar 

  • Elias D, Meilin A, Ablamunits V, Birk OS, Carmi P, Konen-Waisman S, Cohen IR (1997) Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes 46:758–764

    Article  CAS  PubMed  Google Scholar 

  • Elinav E, Adam N, Waks T, Eshhar Z (2009) Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor. Gastroenterology 136:1721–1731

    Article  CAS  PubMed  Google Scholar 

  • Ellegard L, Bosaeus I, Nordgren S, Bengtsson BA (1997) Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome. Ann Surg 225:88–96

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Faria AM, Weiner HL (2006a) Oral tolerance and TGF-beta-producing cells. Inflamm Allergy Drug Targets 5:179–190

    Article  CAS  PubMed  Google Scholar 

  • Faria AM, Weiner HL (2006b) Oral tolerance: therapeutic implications for autoimmune diseases. Clin Dev Immunol 13:143–157

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R (2003) Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 144:5149–5158

    Article  CAS  PubMed  Google Scholar 

  • Fenalti G, Rowley MJ (2008) GAD65 as a prototypic autoantigen. J Autoimmun 31:228–232

    Article  CAS  PubMed  Google Scholar 

  • Feutren G, Papoz L, Assan R, Vialettes B, Karsenty G, Vexiau P, Du Rostu H, Rodier M, Sirmai J, Lallemand A et al (1986) Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial. Lancet 2:119–124

    Article  CAS  PubMed  Google Scholar 

  • Fiocchi C (1997) Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. Am J Physiol 273:G769–G775

    CAS  PubMed  Google Scholar 

  • Fiorina P, Voltarelli J, Zavazava N (2011) Immunological applications of stem cells in type 1 diabetes. Endocr Rev 32:725–754

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Flint JM (1912) The effect of extensive resection of small intestine. Bull Johns Hopkins Hosp 23:127–144

    Google Scholar 

  • Flomenberg N, Devine SM, Dipersio JF, Liesveld JL, McCarty JM, Rowley SD, Vesole DH, Badel K, Calandra G (2005) The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 106:1867–1874

    Article  CAS  PubMed  Google Scholar 

  • Flores AI, Gomez-Gomez GJ, Masedo-Gonzalez A, Martinez-Montiel MP (2015) Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy? World J Stem Cells 7:343–351

    Article  PubMed  PubMed Central  Google Scholar 

  • Forbes GM, Sturm MJ, Leong RW, Sparrow MP, Segarajasingam D, Cummins AG, Phillips M, Herrmann RP (2014) A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn’s disease refractory to biologic therapy. Clin Gastroenterol Hepatol 12:64–71

    Article  PubMed  Google Scholar 

  • Fraenkel M, Ketzinel-Gilad M, Ariav Y, Pappo O, Karaca M, Castel J, Berthault MF, Magnan C, Cerasi E, Kaiser N, Leibowitz G (2008) mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes 57:945–957

    Article  CAS  PubMed  Google Scholar 

  • Friel R, van der Sar S, Mee PJ (2005) Embryonic stem cells: understanding their history, cell biology and signalling. Adv Drug Deliv Rev 57:1894–1903

    Article  CAS  PubMed  Google Scholar 

  • Friend PJ, Hale G, Chatenoud L, Rebello P, Bradley J, Thiru S, Phillips JM, Waldmann H (1999) Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection. Transplantation 68:1632–1637

    Article  CAS  PubMed  Google Scholar 

  • Gabe SM, Jeppesen PB, Pape UF, Youssef NN (2014) STEPS-2, a 2-year, multicenter, open-label clinical trial: safety and efficacy of long-term teduglutide 0.05-mg/kg/day treatment of adults with intestinal failure associated with short bowel syndrome. Poster #199 presented at the 7th European Conference on Rare Diseases & Orphan Products

    Google Scholar 

  • Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA (2005) A phase I clinical trial of the treatment of Crohn’s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 48:1416–1423

    Article  PubMed  Google Scholar 

  • Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, De La Quintana P, Garcia-Arranz M, Pascual M (2009) Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 52:79–86

    Article  PubMed  Google Scholar 

  • Garkavenko O, Dieckhoff B, Wynyard S, Denner J, Elliott RB, Tan PL, Croxson MC (2008) Absence of transmission of potentially xenotic viruses in a prospective pig to primate islet xenotransplantation study. J Med Virol 80:2046–2052

    Article  CAS  PubMed  Google Scholar 

  • Gersemann M, Becker S, Kubler I, Koslowski M, Wang G, Herrlinger KR, Griger J, Fritz P, Fellermann K, Schwab M, Wehkamp J, Stange EF (2009) Differences in goblet cell differentiation between Crohn’s disease and ulcerative colitis. Differentiation 77(1):84–94. doi:10.1016/j.diff.2008.09.008. Epub 2008 Oct 22

    Article  CAS  PubMed  Google Scholar 

  • Gersemann M, Wehkamp J, Stange EF (2012) Innate immune dysfunction in inflammatory bowel disease. J Intern Med 271(5):421–428. doi:10.1111/j.1365-2796.2012.02515.x. Epub 2012 Feb 13

    Article  CAS  PubMed  Google Scholar 

  • Gianani R, Eisenbarth GS (2005) The stages of type 1A diabetes: 2005. Immunol Rev 204:232–249

    Article  CAS  PubMed  Google Scholar 

  • Gillespie KM (2006) Type 1 diabetes: pathogenesis and prevention. CMAJ 175:165–170

    Article  PubMed  PubMed Central  Google Scholar 

  • Ginsberg-Fellner F, Witt ME, Fedun B, Taub F, Dobersen MJ, McEvoy RC, Cooper LZ, Notkins AL, Rubinstein P (1985) Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome. Rev Infect Dis 7(Suppl 1):S170–S176

    Article  PubMed  Google Scholar 

  • Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schaffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, Hatscher N, Pfeifer D, Sykora KW, Sauer M, Kreipe H, Lacher M, Nustede R, Woellner C, Baumann U, Salzer U, Koletzko S, Shah N, Segal AW, Sauerbrey A, Buderus S, Snapper SB, Grimbacher B, Klein C (2009) Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 361:2033–2045

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gouttebel MC, Astre C, Briand D, Saint-Aubert B, Girardot PM, Joyeux H (1992) Influence of N-acetylglutamine or glutamine infusion on plasma amino acid concentrations during the early phase of small-bowel adaptation in the dog. JPEN J Parenter Enteral Nutr 16:117–121

    Article  CAS  PubMed  Google Scholar 

  • Gratwohl A, Brand R, Frassoni F, Rocha V, Niederwieser D, Reusser P, Einsele H, Cordonnier C (2005) Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant 36:757–769

    Article  CAS  PubMed  Google Scholar 

  • Gruessner AC, Sutherland DE (2008) Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). Clin Transpl 2008:45–56

    Google Scholar 

  • Gu Y, Wu ZH, Xie JX, Jin DY, Zhuo HC (2001) Effects of growth hormone (rhGH) and glutamine supplemented parenteral nutrition on intestinal adaptation in short bowel rats. Clin Nutr 20:159–166

    Article  CAS  PubMed  Google Scholar 

  • Guan X, Karpen HE, Stephens J, Bukowski JT, Niu S, Zhang G, Stoll B, Finegold MJ, Holst JJ, Hadsell D, Nichols BL, Burrin DG (2006) GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology 130:150–164

    Article  CAS  PubMed  Google Scholar 

  • Guleria I, Gubbels Bupp M, Dada S, Fife B, Tang Q, Ansari MJ, Trikudanathan S, Vadivel N, Fiorina P, Yagita H, Azuma M, Atkinson M, Bluestone JA, Sayegh MH (2007) Mechanisms of PDL1-mediated regulation of autoimmune diabetes. Clin Immunol 125:16–25

    Article  CAS  PubMed  Google Scholar 

  • Guo Z, Wu T, Kirchhof N, Mital D, Williams JW, Azuma M, Sutherland DE, Hering BJ (2001) Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection. Transplantation 71:1656–1665

    Article  CAS  PubMed  Google Scholar 

  • Gutstein NL, Seaman WE, Scott JH, Wofsy D (1986) Induction of immune tolerance by administration of monoclonal antibody to L3T4. J Immunol 137:1127–1132

    CAS  PubMed  Google Scholar 

  • Haegebarth A, Clevers H (2009) Wnt signaling, lgr5, and stem cells in the intestine and skin. Am J Pathol 174:715–721

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Harrison LC, Dempsey-Collier M, Kramer DR, Takahashi K (1996) Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J Exp Med 184:2167–2174

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Harrison LC, Honeyman MC, Steele CE, Stone NL, Sarugeri E, Bonifacio E, Couper JJ, Colman PG (2004) Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes. Diabetes Care 27:2348–2355

    Article  CAS  PubMed  Google Scholar 

  • Herold KC, Bluestone JA (2011) Type 1 diabetes immunotherapy: is the glass half empty or half full? Sci Transl Med 3:95fs1

    Google Scholar 

  • Hjorth M, Axelsson S, Ryden A, Faresjo M, Ludvigsson J, Casas R (2011) GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients. Clin Immunol 138:117–126

    Google Scholar 

  • Horvath L, Cervenak L, Oroszlan M, Prohaszka Z, Uray K, Hudecz F, Baranyi E, Madacsy L, Singh M, Romics L, Fust G, Panczel P (2002) Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus. Immunol Lett 80(3):155–162

    Article  CAS  PubMed  Google Scholar 

  • Hu CY, Rodriguez-Pinto D, Du W, Ahuja A, Henegariu O, Wong FS, Shlomchik MJ, Wen L (2007) Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest 117:3857–3867

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Iakoubov R, Lauffer LM, Trivedi S, Kim YI, Brubaker PL (2009) Carcinogenic effects of exogenous and endogenous glucagon-like peptide-2 in azoxymethane-treated mice. Endocrinology 150:4033–4043

    Article  CAS  PubMed  Google Scholar 

  • Ilonen J, Sjoroos M, Knip M, Veijola R, Simell O, Akerblom HK, Paschou P, Bozas E, Havarani B, Malamitsi-Puchner A, Thymelli J, Vazeou A, Bartsocas CS (2002) Estimation of genetic risk for type 1 diabetes. Am J Med Genet 115:30–36

    Article  PubMed  Google Scholar 

  • Inoue Y, Copeland EM, Souba WW (1994) Growth hormone enhances amino acid uptake by the human small intestine. Ann Surg 219:715–722

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jacobs LR (1983) Effects of dietary fiber on mucosal growth and cell proliferation in the small intestine of the rat: a comparison of oat bran, pectin, and guar with total fiber deprivation. Am J Clin Nutr 37:954–960

    CAS  PubMed  Google Scholar 

  • Jaeckel E, Mpofu N, Saal N, Manns MP (2008) Role of regulatory T cells for the treatment of type 1 diabetes mellitus. Horm Metab Res 40:126–136

    Article  CAS  PubMed  Google Scholar 

  • Jena B, Dotti G, Cooper LJ (2011) Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor. Blood 116:1035–1044

    Google Scholar 

  • Jeppesen PB, Szkudlarek J, Hoy CE, Mortensen PB (2001) Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study. Scand J Gastroenterol 36:48–54

    CAS  PubMed  Google Scholar 

  • Jeppesen PB, Sanguinetti EL, Buchman A, Howard L, Scolapio JS, Ziegler TR, Gregory J, Tappenden KA, Holst J, Mortensen PB (2005) Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 54:1224–1231

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O’Keefe SJ (2011) Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut 60:902–914

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kapoor S, Wilson AG, Sharrack B, Lobo A, Akil M, Sun L, Dalley CD, Snowden JA (2007) Haemopoietic stem cell transplantation--an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology. Hematology 12:179–191

    Article  CAS  PubMed  Google Scholar 

  • Katz JD, Wang B, Haskins K, Benoist C, Mathis D (1993) Following a diabetogenic T cell from genesis through pathogenesis. Cell 74:1089–1100

    Article  CAS  PubMed  Google Scholar 

  • Kazkaz H, Isenberg D (2004) Anti B cell therapy (rituximab) in the treatment of autoimmune diseases. Curr Opin Pharmacol 4:398–402

    Article  CAS  PubMed  Google Scholar 

  • Kishimoto H, Sprent J (2001) A defect in central tolerance in NOD mice. Nat Immunol 2:1025–1031

    Article  CAS  PubMed  Google Scholar 

  • Kobayashi T, Arefanian H, Harb G, Tredget EB, Rajotte RV, Korbutt GS, Rayat GR (2008) Prolonged survival of microencapsulated neonatal porcine islet xenografts in immune-competent mice without antirejection therapy. Cell Transplant 17:1243–1256

    Article  PubMed  Google Scholar 

  • Kolterman OG, Buse JB, Fineman MS, Gaines E, Heintz S, Bicsak TA, Taylor K, Kim D, Aisporna M, Wang Y, Baron AD (2003) Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab 88:3082–3089

    Article  CAS  PubMed  Google Scholar 

  • Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ (2005) Sargramostim for active Crohn’s disease. N Engl J Med 352:2193–2201

    Article  CAS  PubMed  Google Scholar 

  • Koslowski MJ, Kubler I, Chamaillard M, Schaeffeler E, Reinisch W, Wang G, Beisner J, Teml A, Peyrin-Biroulet L, Winter S, Herrlinger KR, Rutgeerts P, Vermeire S, Cooney R, Fellermann K, Jewell D, Bevins CL, Schwab M, Stange EF, Wehkamp J (2009) Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn’s disease. PLoS One 4:e4496

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Koslowski MJ, Teltschik Z, Beisner J, Schaeffeler E, Wang G, K++bler I, Gersemann M, Cooney R, Jewell D, Reinisch W, Vermeire S, Rutgeerts P, Schwab M, Stange EF, Wehkamp J (2012) Association of a functional variant in the Wnt Co-receptor LRP6 with early onset ileal Crohn’s disease. PLoS Genet 8:e1002523

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kreisel W, Potthoff K, Bertz H, Schmitt-Graeff A, Ruf G, Rasenack J, Finke J (2003) Complete remission of Crohn’s disease after high-dose cyclophosphamide and autologous stem cell transplantation. Bone Marrow Transplant 32:337–340

    Article  CAS  PubMed  Google Scholar 

  • Kremer JM, Genant HK, Moreland LW, Russell AS, Emery P, Abud-Mendoza C, Szechinski J, Li T, Teng J, Becker JC, Westhovens R (2008) Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate. Arthritis Rheum 58:953–963

    Article  CAS  PubMed  Google Scholar 

  • Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, Young H, Richardson M, Smart NG, Cunningham J, Agulnick AD, D’Amour KA, Carpenter MK, Baetge EE (2008) Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26:443–452

    Article  CAS  PubMed  Google Scholar 

  • Kupila A, Sipila J, Keskinen P, Simell T, Knip M, Pulkki K, Simell O (2003) Intranasally administered insulin intended for prevention of type 1 diabetes--a safety study in healthy adults. Diabetes Metab Res Rev 19:415–420

    Article  CAS  PubMed  Google Scholar 

  • Lazar L, Ofan R, Weintrob N, Avron A, Tamir M, Elias D, Phillip M, Josefsberg Z (2007) Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study. Diabetes Metab Res Rev 23:286–291

    Article  CAS  PubMed  Google Scholar 

  • Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD, Prockop DJ (2006) Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A 103:17438–17443

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee WY, Park KJ, Cho YB, Yoon SN, Song KH, do Kim S, Jung SH et al (2013) Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn’s fistula. Stem Cells 31:2575–2581

    Article  CAS  PubMed  Google Scholar 

  • Li L, El-Kholy W, Rhodes CJ, Brubaker PL (2005) Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B. Diabetologia 48:1339–1349

    Article  CAS  PubMed  Google Scholar 

  • Li Y, Zhang R, Qiao H, Zhang H, Wang Y, Yuan H, Liu Q, Liu D, Chen L, Pei X (2007) Generation of insulin-producing cells from PDX-1 gene-modified human mesenchymal stem cells. J Cell Physiol 211:36–44

    Article  CAS  PubMed  Google Scholar 

  • Liang J, Zhang H, Wang D, Feng X, Wang H, Hua B, Liu B, Sun L (2012) Allogeneic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease. Gut 61:468–469

    Article  PubMed  Google Scholar 

  • Lipsett M, Hanley S, Castellarin M, Austin E, Suarez-Pinzon WL, Rabinovitch A, Rosenberg L (2007) The role of islet neogenesis-associated protein (INGAP) in islet neogenesis. Cell Biochem Biophys 48:127–137

    Article  CAS  PubMed  Google Scholar 

  • Looney RJ (2005) B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis. Rheumatology (Oxford) 44(Suppl 2):ii13–ii17

    CAS  Google Scholar 

  • Lopez-Cubero SO, Sullivan KM, McDonald GB (1998) Course of Crohn’s disease after allogeneic marrow transplantation. Gastroenterology 114:433–440

    Article  CAS  PubMed  Google Scholar 

  • Ludvigsson J, Faresjo M, Hjorth M, Axelsson S, Cheramy M, Pihl M, Vaarala O, Forsander G, Ivarsson S, Johansson C, Lindh A, Nilsson NO, Aman J, Ortqvist E, Zerhouni P, Casas R (2008) GAD treatment and insulin secretion in recent-onset type 1 diabetes. N Engl J Med 359:215–218

    Article  Google Scholar 

  • Lund PK (1998) Molecular basis of intestinal adaptation: the role of the insulin-like growth factor system. Ann N Y Acad Sci 859:18–36

    Article  CAS  PubMed  Google Scholar 

  • Ma SW, Zhao DL, Yin ZQ, Mukherjee R, Singh B, Qin HY, Stiller CR, Jevnikar AM (1997) Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nat Med 3:793–796

    Article  CAS  PubMed  Google Scholar 

  • Madec AM, Mallone R, Afonso G, Abou Mrad E, Mesnier A, Eljaafari A, Thivolet C (2009) Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia 52:1391–1399

    Article  CAS  PubMed  Google Scholar 

  • Maehr R (2011) iPS cells in type 1 diabetes research and treatment. Clin Pharmacol Ther 89:750–753

    Article  CAS  PubMed  Google Scholar 

  • Masteller EL, Warner MR, Tang Q, Tarbell KV, McDevitt H, Bluestone JA (2005) Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J Immunol 175:3053–3059

    Article  CAS  PubMed  Google Scholar 

  • Matveyenko AV, Georgia S, Bhushan A, Butler PC (2010) Inconsistent formation and nonfunction of insulin-positive cells from pancreatic endoderm derived from human embryonic stem cells in athymic nude rats. Am J Physiol Endocrinol Metab 299:713–720

    Article  CAS  Google Scholar 

  • McCall MD, Toso C, Baetge EE, Shapiro AM (2009) Are stem cells a cure for diabetes? Clin Sci (Lond) 118:87–97

    Article  Google Scholar 

  • Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H (2013) Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med 2:455–463

    Article  PubMed  PubMed Central  Google Scholar 

  • Monti P, Scirpoli M, Maffi P, Piemonti L, Secchi A, Bonifacio E, Roncarolo MG, Battaglia M (2008) Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells. Diabetes 57:2341–2347

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Morgan RA, Dudley ME, Rosenberg SA (2010) Adoptive cell therapy: genetic modification to redirect effector cell specificity. Cancer J 16:336–341

    Article  CAS  PubMed  Google Scholar 

  • Muir A, Peck A, Clare-Salzler M, Song YH, Cornelius J, Luchetta R, Krischer J, Maclaren N (1995) Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest 95:628–634

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, Yu L, Wegmann DR, Hutton JC, Elliott JF, Eisenbarth GS (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435:220–223

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nejentsev S, Sjoroos M, Soukka T, Knip M, Simell O, Lovgren T, Ilonen J (1999) Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet Med 16:985–992

    Article  CAS  PubMed  Google Scholar 

  • Nightingale JM, Lennard-Jones JE (1993) The short bowel syndrome: what’s new and old? Dig Dis 11:12–31

    Article  CAS  PubMed  Google Scholar 

  • Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA (1996) The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 59:1134–1148

    CAS  PubMed  PubMed Central  Google Scholar 

  • O’Keefe SJ, Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B (2013) Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure. Clin Gastroenterol Hepatol 11:815–823

    Article  PubMed  CAS  Google Scholar 

  • Ogawa N, List JF, Habener JF, Maki T (2004) Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. Diabetes 53:1700–1705

    Article  CAS  PubMed  Google Scholar 

  • Onken J, Gallup D, Hanson J (2006) Successful outpatient treatment of refractory Crohn’s disease using adult mesenchymal stem cells. ACG 2006 Final Program Book, p 121

    Google Scholar 

  • Onken J, Jaffe T, Custer L (2008) Long-term safety of prochymal adult mesenchymal stem cells in Crohn’s disease. Gastroenterology 134:A-661

    Article  Google Scholar 

  • Orskov C, Hartmann B, Poulsen SS, Thulesen J, Hare KJ, Holst JJ (2005) GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regul Pept 124:105–112

    Article  CAS  PubMed  Google Scholar 

  • Oyama Y, Craig RM, Traynor AE, Quigley K, Statkute L, Halverson A, Brush M, Verda L, Kowalska B, Krosnjar N, Kletzel M, Whitington PF, Burt RK (2005) Autologous hematopoietic stem cell transplantation in patients with refractory Crohn’s disease. Gastroenterology 128:552–563

    Article  PubMed  Google Scholar 

  • Parekkadan B, Milwid JM (2010) Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12:87–117

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Parving HH, Tarnow L, Nielsen FS, Rossing P, Mandrup-Poulsen T, Osterby R, Nerup J (1999) Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study. Diabetes Care 22:478–483

    Article  CAS  PubMed  Google Scholar 

  • Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373:2027–2033

    Article  PubMed  Google Scholar 

  • Peltola H, Davidkin I, Paunio M, Valle M, Leinikki P, Heinonen OP (2000) Mumps and rubella eliminated from Finland. JAMA 284:2643–2647

    Article  CAS  PubMed  Google Scholar 

  • Pironi L, Forbes A, Joly F, Colomb V, Lyszkowska M, Van GA, Baxter J, Thul P, Hebuterne X, Gambarara M, Gottrand F, Moreno Villares JM, Messing B, Goulet O, Staun M (2008) Survival of patients identified as candidates for intestinal transplantation: a 3-year prospective follow-up. Gastroenterology 135:61–71

    Article  PubMed  Google Scholar 

  • Pironi L, Joly F, Forbes A, Colomb V, Lyszkowska M, Baxter J, Gabe S, Hebuterne X, Gambarara M, Gottrand F, Cuerda C, Thul P, Messing B, Goulet O, Staun M, Van GA (2011) Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut 60:17–25

    Article  PubMed  Google Scholar 

  • Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147

    Article  CAS  PubMed  Google Scholar 

  • Playford RJ, Marchbank T, Goodlad RA, Chinery RA, Poulsom R, Hanby AM (1996) Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci U S A 93:2137–2142

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pozzilli P (2002) The DPT-1 trial: a negative result with lessons for future type 1 diabetes prevention. Diabetes Metab Res Rev 18:257–259

    Article  PubMed  Google Scholar 

  • Pozzilli P, Pitocco D, Visalli N, Cavallo MG, Buzzetti R, Crino A, Spera S, Suraci C, Multari G, Cervoni M, Manca Bitti ML, Matteoli MC, Marietti G, Ferrazzoli F, Cassone Faldetta MR, Giordano C, Sbriglia M, Sarugeri E, Ghirlanda G (2000) No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group. Diabetologia 43:1000–1004

    Article  CAS  PubMed  Google Scholar 

  • Qi Y, Jiang D, Sindrilaru A, Stegemann A, Schatz S, Treiber N, Rojewski M et al (2014) TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds. J Invest Dermatol 134:526–537

    Article  CAS  PubMed  Google Scholar 

  • Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen IR (2001) Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 358:1749–1753

    Article  CAS  PubMed  Google Scholar 

  • Raz I, Avron A, Tamir M, Metzger M, Symer L, Eldor R, Cohen IR, Elias D (2007) Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial. Diabetes Metab Res Rev 23:292–298

    Article  CAS  PubMed  Google Scholar 

  • Rigby MR, Trexler AM, Pearson TC, Larsen CP (2008) CD28/CD154 blockade prevents autoimmune diabetes by inducing nondeletional tolerance after effector t-cell inhibition and regulatory T-cell expansion. Diabetes 57:2672–2683

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Roep BO, Atkinson M, von Herrath M (2004) Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes. Nat Rev Immunol 4:989–997

    Article  CAS  PubMed  Google Scholar 

  • Rooman I, Bouwens L (2004) Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan. Diabetologia 47:259–265

    Article  CAS  PubMed  Google Scholar 

  • Rooman I, Lardon J, Bouwens L (2002) Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue. Diabetes 51:686–690

    Article  CAS  PubMed  Google Scholar 

  • Rosenberg L, Lipsett M, Yoon JW, Prentki M, Wang R, Jun HS, Pittenger GL, Taylor-Fishwick D, Vinik AI (2004) A pentadecapeptide fragment of islet neogenesis-associated protein increases beta-cell mass and reverses diabetes in C57BL/6J mice. Ann Surg 240:875–884

    Article  PubMed  PubMed Central  Google Scholar 

  • Rother KI, Spain LM, Wesley RA, Digon BJ 3rd, Baron A, Chen K, Nelson P, Dosch HM, Palmer JP, Brooks-Worrell B, Ring M, Harlan DM (2009) Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes. Diabetes Care 32:2251–2257

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rowland KJ, Brubaker PL (2011) The “cryptic” mechanism of action of glucagon-like peptide-2. Am J Physiol Gastrointest Liver Physiol 301:G1–G8

    Article  CAS  PubMed  Google Scholar 

  • Salomon B, Bluestone JA (2001) Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 19:225–252

    Article  CAS  PubMed  Google Scholar 

  • Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone JA (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431–440

    Article  CAS  PubMed  Google Scholar 

  • Sandborn WJ, Sands BE, Wolf DC, Valentine JF, Safdi M, Katz S, Isaacs KL, Wruble LD, Katz J, Present DH, Loftus EV Jr, Graeme-Cook F, Odenheimer DJ, Hanauer SB (2003) Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Aliment Pharmacol Ther 17:1355–1364

    Article  CAS  PubMed  Google Scholar 

  • Scheppach W, Loges C, Bartram P, Christl SU, Richter F, Dusel G, Stehle P, Fuerst P, Kasper H (1994) Effect of free glutamine and alanyl-glutamine dipeptide on mucosal proliferation of the human ileum and colon. Gastroenterology 107:429–434

    Article  CAS  PubMed  Google Scholar 

  • Scolapio JS, Camilleri M, Fleming CR, Oenning LV, Burton DD, Sebo TJ, Batts KP, Kelly DG (1997) Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 113:1074–1081

    Article  CAS  PubMed  Google Scholar 

  • Scott RB, Kirk D, MacNaughton WK, Meddings JB (1998) GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol 275:G911–G921

    CAS  PubMed  Google Scholar 

  • Seguy D, Vahedi K, Kapel N, Souberbielle JC, Messing B (2003) Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology 124:293–302

    Article  CAS  PubMed  Google Scholar 

  • Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, Rouas-Freiss N, Carosella ED, Deschaseaux F (2008) Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 26:212–222

    Article  CAS  PubMed  Google Scholar 

  • Semont A, Demarquay C, Bessout R, Durand C, Benderitter M, Mathieu N (2013) Mesenchymal stem cell therapy stimulates endogenous host progenitor cells to improve colonic epithelial regeneration. PLoS One 8:e70170

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230–238

    Article  CAS  PubMed  Google Scholar 

  • Sherry NA, Chen W, Kushner JA, Glandt M, Tang Q, Tsai S, Santamaria P, Bluestone JA, Brillantes AM, Herold KC (2007) Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells. Endocrinology 148:5136–5144

    Article  CAS  PubMed  Google Scholar 

  • Silverstein J, Maclaren N, Riley W, Spillar R, Radjenovic D, Johnson S (1988) Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus. N Engl J Med 319:599–604

    Article  CAS  PubMed  Google Scholar 

  • Sinha A, Nightingale J, West KP, Berlanga-Acosta J, Playford RJ (2003) Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med 349:350–357

    Article  CAS  PubMed  Google Scholar 

  • Slonim AE, Bulone L, Damore MB, Goldberg T, Wingertzahn MA, McKinley MJ (2000) A preliminary study of growth hormone therapy for Crohn’s disease. N Engl J Med 342:1633–1637

    Article  CAS  PubMed  Google Scholar 

  • Snarski E, Milczarczyk A, Torosian T, Paluszewska M, Urbanowska E, Krol M, Boguradzki P, Jedynasty K, Franek E, Wiktor-Jedrzejczak W (2011) Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I. Bone Marrow Transplant 46:562–566

    Google Scholar 

  • Snowden JA, Pearce RM, Lee J, Kirkland K, Gilleece M, Veys P, Clark RE et al (2012) Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997–2009. Br J Haematol 157:742–746

    Article  PubMed  Google Scholar 

  • Stefanovic S, Abboud N, Desilets S, Nury D, Cowan C, Puceat M (2009) Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. J Cell Biol 186:665–673

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stiller CR, Dupre J, Gent M, Heinrichs D, Jenner MR, Keown PA, Laupacis A, Martell R, Rodger NW, Wolfe BM et al (1987) Effects of cyclosporine in recent-onset juvenile type 1 diabetes: impact of age and duration of disease. J Pediatr 111:1069–1072

    Article  CAS  PubMed  Google Scholar 

  • Suarez-Pinzon WL, Yan Y, Power R, Brand SJ, Rabinovitch A (2005) Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice. Diabetes 54:2596–2601

    Article  CAS  PubMed  Google Scholar 

  • Suarez-Pinzon WL, Power RF, Yan Y, Wasserfall C, Atkinson M, Rabinovitch A (2008) Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice. Diabetes 57:3281–3288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sun Y, Chen L, Hou XG, Hou WK, Dong JJ, Sun L, Tang KX, Wang B, Song J, Li H, Wang KX (2007) Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin Med J (Engl) 120:771–776

    CAS  Google Scholar 

  • Tamada H, Nezu R, Matsuo Y, Imamura I, Takagi Y, Okada A (1993) Alanyl glutamine-enriched total parenteral nutrition restores intestinal adaptation after either proximal or distal massive resection in rats. JPEN J Parenter Enteral Nutr 17:236–242

    Article  CAS  PubMed  Google Scholar 

  • Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J, Masteller EL, McDevitt H, Bonyhadi M, Bluestone JA (2004) In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199:1455–1465

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tarbell KV, Yamazaki S, Steinman RM (2006) The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity. Semin Immunol 18:93–102

    Article  CAS  PubMed  Google Scholar 

  • Tee CT, Wallis K, Gabe SM (2011) Emerging treatment options for short bowel syndrome: potential role of teduglutide. Clin Exp Gastroenterol 4:189–196

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, Kaufman DL (1996a) Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 183:1561–1567

    Article  CAS  PubMed  Google Scholar 

  • Tian J, Clare-Salzler M, Herschenfeld A, Middleton B, Newman D, Mueller R, Arita S, Evans C, Atkinson MA, Mullen Y, Sarvetnick N, Tobin AJ, Lehmann PV, Kaufman DL (1996b) Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat Med 2:1348–1353

    Article  CAS  PubMed  Google Scholar 

  • Tisch R, Liblau RS, Yang XD, Liblau P, McDevitt HO (1998) Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes 47:894–899

    Article  CAS  PubMed  Google Scholar 

  • Tisch R, Wang B, Serreze DV (1999) Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. J Immunol 163:1178–1187

    CAS  PubMed  Google Scholar 

  • Tuch BE, Hughes TC, Evans MD (2011) Encapsulated pancreatic progenitors derived from human embryonic stem cells as a therapy for insulin-dependent diabetes. Diabetes Metab Res Rev 27:928–932

    Article  CAS  PubMed  Google Scholar 

  • Ugrasbul F, Moore WV, Tong PY, Kover KL (2008) Prevention of diabetes: effect of mycophenolate mofetil and anti-CD25 on onset of diabetes in the DRBB rat. Pediatr Diabetes 9(6):596–601. doi:10.1111/j.1399-5448.2008.00417.x. Epub 2008 May 21

    Article  CAS  PubMed  Google Scholar 

  • van Belle TL, Coppieters KT, von Herrath MG (2011) Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 91:79–118

    Article  PubMed  CAS  Google Scholar 

  • van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, Yarmush ML (2008) Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 47:1634–1643

    Article  PubMed  CAS  Google Scholar 

  • Vardanyan M, Parkin E, Gruessner C, Rodriguez Rilo HL (2010) Pancreas vs. islet transplantation: a call on the future. Curr Opin Organ Transpl 15:124–130

    Google Scholar 

  • Vehik K, Cuthbertson D, Ruhlig H, Schatz DA, Peakman M, Krischer JP (2011) Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial. Diabetes Care 34:1585–1590

    Article  PubMed  PubMed Central  Google Scholar 

  • Vipperla K, O’Keefe SJ (2014) Targeted therapy of short-bowel syndrome with teduglutide: the new kid on the block. Clin Exp Gastroenterol 7:489–495

    Article  PubMed  PubMed Central  Google Scholar 

  • Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, Coutinho M, Malmegrim KC, Foss-Freitas MC, Simoes BP, Foss MC, Squiers E, Burt RK (2007) Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 297:1568–1576

    Article  CAS  PubMed  Google Scholar 

  • von Herrath M, Sanda S, Herold K (2007) Type 1 diabetes as a relapsing-remitting disease? Nat Rev Immunol 7:988–994

    Article  CAS  Google Scholar 

  • Voswinkel J, Francois S, Gorin NC, Chapel A (2013) Gastro-intestinal autoimmunity: preclinical experiences and successful therapy of fistulizing bowel diseases and gut Graft versus host disease by mesenchymal stromal cells. Immunol Res 56:241–248

    Article  PubMed  Google Scholar 

  • Waldmann H, Cobbold S (1998) How do monoclonal antibodies induce tolerance? A role for infectious tolerance? Annu Rev Immunol 16:619–644

    Article  CAS  PubMed  Google Scholar 

  • Waldron-Lynch F, Herold KC (2009) Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvage. Endocrinol Metab Clin North Am 38:303–317

    Article  CAS  PubMed  Google Scholar 

  • Waldron-Lynch F, Herold KC (2011) Immunomodulatory therapy to preserve pancreatic beta-cell function in type 1 diabetes. Nat Rev Drug Discov 10:439–452

    Article  CAS  PubMed  Google Scholar 

  • Wales PW, Nasr A, De Silva N, Yamada J (2010) Human growth hormone and glutamine for patients with short bowel syndrome. Cochrane Database Syst Rev 16(6), CD006321. doi:10.1002/14651858. CD006321.pub2

    Google Scholar 

  • Wang TC, Bonner-Weir S, Oates PS, Chulak M, Simon B, Merlino GT, Schmidt EV, Brand SJ (1993) Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells. J Clin Invest 92:1349–1356

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang RN, Kloppel G, Bouwens L (1995) Duct- to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats. Diabetologia 38:1405–1411

    Article  CAS  PubMed  Google Scholar 

  • Wherrett DK, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Herold KC, Marks JB, Monzavi R, Moran A, Orban T, Palmer JP, Raskin P, Rodriguez H, Schatz D, Wilson DM, Krischer JP, Skyler JS (2011) Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial. Lancet 378:319–327

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wu AJ, Hua H, Munson SH, McDevitt HO (2002) Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice. Proc Natl Acad Sci U S A 99:12287–12292

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xu G, Stoffers DA, Habener JF, Bonner-Weir S (1999) Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48:2270–2276

    Article  CAS  PubMed  Google Scholar 

  • Xu X, D’Hoker J, Stange G, Bonne S, De Leu N, Xiao X, Van de Casteele M, Mellitzer G, Ling Z, Pipeleers D, Bouwens L, Scharfmann R, Gradwohl G, Heimberg H (2008) Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 132:197–207

    Article  CAS  PubMed  Google Scholar 

  • You S, Leforban B, Garcia C, Bach JF, Bluestone JA, Chatenoud L (2007) Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc Natl Acad Sci U S A 104:6335–6340

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yusta B, Huang L, Munroe D, Wolff G, Fantaske R, Sharma S, Demchyshyn L, Asa SL, Drucker DJ (2000) Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology 119:744–755

    Article  CAS  PubMed  Google Scholar 

  • Zahr E, Molano RD, Pileggi A, Ichii H, Jose SS, Bocca N, An W, Gonzalez-Quintana J, Fraker C, Ricordi C, Inverardi L (2007) Rapamycin impairs in vivo proliferation of islet beta-cells. Transplantation 84:1576–1583

    Article  CAS  PubMed  Google Scholar 

  • Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL (1991) Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci U S A 88:10252–10256

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang YW, Ding LS, Lai MD (2003) Reg gene family and human diseases. World J Gastroenterol 9:2635–2641

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang N, Su D, Qu S, Tse T, Bottino R, Balamurugan AN, Xu J, Bromberg JS, Dong HH (2006) Sirolimus is associated with reduced islet engraftment and impaired beta-cell function. Diabetes 55:2429–2436

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastoenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany

    Carsten Keil, Elmar Jäckel, Michael P. Manns & Oliver Bachmann

Authors
  1. Carsten Keil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elmar Jäckel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael P. Manns
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oliver Bachmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael P. Manns .

Editor information

Editors and Affiliations

  1. Department of Cardiac Surgery and Refere, University of Rostock, Rostock, Mecklenburg-Vorpomm., Germany

    Gustav Steinhoff

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Keil, C., Jäckel, E., Manns, M.P., Bachmann, O. (2016). Gastrointestinal Tract and Endocrine System. In: Steinhoff, G. (eds) Regenerative Medicine - from Protocol to Patient. Springer, Cham. https://doi.org/10.1007/978-3-319-28386-9_6

Download citation

Publish with us

Policies and ethics

Search

Navigation